Page last updated: 2024-09-03

imatinib mesylate and Adenocarcinoma, Endometrioid

imatinib mesylate has been researched along with Adenocarcinoma, Endometrioid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Broaddus, RR; Burke, TW; Gershenson, DM; Lu, KH; Oh, JC; Ramondetta, LM; Schmandt, R; Slomovitz, BM; Wu, W	1

Other Studies

1 other study(ies) available for imatinib mesylate and Adenocarcinoma, Endometrioid

Article	Year
Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. Gynecologic oncology, 2004, Volume: 95, Issue:1 Topics: Antineoplastic Agents; Benzamides; Carcinoma, Endometrioid; Endometrial Neoplasms; Enzyme Inhibitors; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Paraffin Embedding; Phosphorylation; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor	2004

Article

Year

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.

Gynecologic oncology, 2004, Volume: 95, Issue:1

Topics: Antineoplastic Agents; Benzamides; Carcinoma, Endometrioid; Endometrial Neoplasms; Enzyme Inhibitors; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Paraffin Embedding; Phosphorylation; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor

2004